Related Experiment Video

Updated: Nov 12, 2025

Author Spotlight: Exploring the Role of FAM83A in Cervical Cancer
04:20

Author Spotlight: Exploring the Role of FAM83A in Cervical Cancer

Published on: February 9, 2024

1.2K

Punicalagin induces ROS-mediated apoptotic cell death through inhibiting STAT3 translocation in lung cancer A549

Le Fang1,2, Hong Wang3, Jie Zhang4

  • 1Department of Clinical Laboratory, The 521 Hospital of Ordnance Industry, Xi'an, Shaanxi, China.

Journal of Biochemical and Molecular Toxicology
|March 15, 2021
PubMed

Insights

Punicalagin, a plant-derived compound, effectively inhibits lung cancer cell growth by triggering programmed cell death (apoptosis). This natural compound shows promise as a novel therapy for non-small cell lung cancer.

Area of Science:

  • Oncology
  • Pharmacology
  • Cell Biology

Background:

  • Lung cancer presents a significant global health challenge with limited therapeutic options and poor survival rates.
  • Existing treatments like chemotherapy, radiotherapy, and surgery offer suboptimal outcomes for many patients.
  • Punicalagin, a natural phytomedicine, has demonstrated potential in inhibiting the progression of various cancer types.

Purpose of the Study:

  • To investigate the antiproliferative effects of punicalagin on human lung cancer A549 cells.
  • To elucidate the mechanism by which punicalagin induces apoptosis, focusing on Signal Transducer and Activator of Transcription 3 (STAT-3) pathway.
  • To evaluate punicalagin's potential as a therapeutic agent for non-small cell lung cancer.

Main Methods:

  • A549 lung cancer cells were treated with varying concentrations of punicalagin (10, 20, 30 μM) for 24 hours.
  • Assessed the cytotoxic effects, reactive oxygen species (ROS) generation, and mitochondrial membrane potential changes.
  • Investigated the impact of punicalagin on STAT-3 translocation, apoptosis-related proteins (Bcl-2, Bax, cytochrome-c), and caspase activation (caspase-9, caspase-3).

Main Results:

  • Punicalagin exhibited dose-dependent toxicity against A549 cells.
  • Treatment with punicalagin induced significant ROS generation, altered mitochondrial membrane potential, and morphological changes indicative of apoptosis.
  • Punicalagin effectively inhibited STAT-3 translocation, downregulated Bcl-2 expression, and upregulated Bax, cytochrome-c, caspase-9, and caspase-3 expression, thereby promoting apoptosis.

Conclusions:

  • Punicalagin demonstrates significant antiproliferative and pro-apoptotic effects on A549 lung cancer cells.
  • The mechanism involves the inhibition of STAT-3 activation and modulation of key apoptosis-related proteins.
  • Punicalagin represents a promising phytomedicine for the treatment of non-small cell lung cancer, warranting further investigation.
Keywords:
STAT-3apoptosislung cancerphytodrugpunicalagin

More Related Videos

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis11:44

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis

Published on: March 30, 2019

7.8K

Related Concept Videos

The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
7.3K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
4.5K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.0K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
10.1K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.8K
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
7.1K